STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers

Petra van der Lelij; Joseph A Newman; Simone Lieb; Julian Jude; Vittorio Katis; Thomas Hoffmann; Matthias Hinterndorfer; Gerd Bader; Norbert Kraut; Mark A Pearson; Jan-Michael Peters; Johannes Zuber; Opher Gileadi; Mark Petronczki

doi:10.26508/lsa.202000725

Research Article

Open Access

STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers

View ORCID ProfilePetra van der Lelij, Joseph A Newman, Simone Lieb, Julian Jude, Vittorio Katis, Thomas Hoffmann, Matthias Hinterndorfer, Gerd Bader, Norbert Kraut, Mark A Pearson, Jan-Michael Peters, Johannes Zuber Correspondence email, Opher Gileadi Correspondence email, View ORCID ProfileMark Petronczki Correspondence email

Petra van der Lelij

1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Petra van der Lelij

Joseph A Newman

2Structural Genomics Consortium, University of Oxford, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Simone Lieb

3Boehringer Ingelheim Regional Center Vienna (RCV) GmbH & Co KG, Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Julian Jude

1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vittorio Katis

2Structural Genomics Consortium, University of Oxford, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas Hoffmann

1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Hinterndorfer

1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gerd Bader

3Boehringer Ingelheim Regional Center Vienna (RCV) GmbH & Co KG, Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Norbert Kraut

3Boehringer Ingelheim Regional Center Vienna (RCV) GmbH & Co KG, Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark A Pearson

3Boehringer Ingelheim Regional Center Vienna (RCV) GmbH & Co KG, Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jan-Michael Peters

1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria

4Medical University of Vienna, VBC, Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johannes Zuber

1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria

4Medical University of Vienna, VBC, Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: johannes.zuber@imp.ac.at

Opher Gileadi

2Structural Genomics Consortium, University of Oxford, Oxford, UK

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: opher.gileadi@sgc.ox.ac.uk

Mark Petronczki

3Boehringer Ingelheim Regional Center Vienna (RCV) GmbH & Co KG, Vienna, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Mark Petronczki
For correspondence: mark_paul.petronczki@boehringer-ingelheim.com

Published 28 May 2020. DOI: 10.26508/lsa.202000725

Article
Figures & Data
Info
Metrics
Reviewer Comments
PDF

Statistics from Altmetric.com

Article usage

Article usage: May 2020 to January 2022

	Abstract	Full	Pdf
May 2020	0	150	53
Jun 2020	25	388	242
Jul 2020	20	232	76
Aug 2020	9	202	64
Sep 2020	6	110	81
Oct 2020	12	128	51
Nov 2020	7	113	47
Dec 2020	4	170	64
Jan 2021	8	161	62
Feb 2021	10	158	59
Mar 2021	5	139	52
Apr 2021	5	132	63
May 2021	5	231	44
Jun 2021	8	171	60
Jul 2021	4	113	50
Aug 2021	11	119	35
Sep 2021	10	114	68
Oct 2021	8	192	75
Nov 2021	6	112	59
Dec 2021	11	153	46
Jan 2022	2	46	19

Cited By...

7 Citations
Google Scholar

PreviousNext

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers

Message Subject (Your Name) has sent you a message from Life Science Alliance

Message Body (Your Name) thought you would like to see the Life Science Alliance web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Exploiting cohesin synthetic lethality

Petra van der Lelij, Joseph A Newman, Simone Lieb, Julian Jude, Vittorio Katis, Thomas Hoffmann, Matthias Hinterndorfer, Gerd Bader, Norbert Kraut, Mark A Pearson, Jan-Michael Peters, Johannes Zuber, Opher Gileadi, Mark Petronczki

Life Science Alliance May 2020, 3 (7) e202000725; DOI: 10.26508/lsa.202000725